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                                      1. INTRODUCTION 
Pain is one of the most important problems associated with personal and social affliction 
worldwide, and it remains an important challenge of modern medicine. The International 
Association for the Study of Pain defined chronic pain as "an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in terms of such 
damage" (Vallath et al., 2013). Unfortunately, some individuals experience pain without an 
obvious injury or suffer protracted pain that persists for months or years after the initial insult. 
This painful condition is usually neuropathic in nature and accounts for a large number of 
patients presenting with chronic, non-malignant pain to clinics. Neuropathic pain is defined as 
neural damage in the nervous system which leads to pain and loss of function. International 
association for the study of pain (IASP) has given a new definition for neuropathic pain as “It is 
initiated or caused by a primary lesion, dysfunction or transitory perturbation of the peripheral or 
central nervous system” (Loeser and Treede., 2008). It commonly occurred in patients with 
cancers, virus infections, diabetes, spinal cord injury, peripheral nerve injury and ischemia. 
Neuropathic pain is characterized by hypersensitivity to nonnoxious (allodynia) and noxious 
(hyperalgesia) stimulation (Baron et al. 2009). Allodynia is mediated via Aβ fibers, and human 
studies have demonstrated that the blockade of Aβ fibers can abolish  allodynia (Torebjork  et  
al.,  1992). Hyperalgesia is mediated via sensitized Aδ fibersor C-fibers (Ziegler et  al.,  1999). 
In  the   periphery the   injured  nerve fibers  releases  several   inflammatory mediators such as 
bradykinin, serotonin,  prostaglandins, adenosine  triphosphate (ATP) and protons, which 
increase the sensitivity and excitability of the nociceptive neurons  either directly or by activation 
of intracellular signaling pathways  (Julius and Basbaum, 2001; Ji et al., 2003) . Calcitonin gene-
related peptide (CGRP) and substance P induce hyperaemia and swelling. This facilitates the 
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invasion of immune cells guided by chemokines to the side of injury.  Immunecells in turn  
release  proinflammatory  mediators  like  prostaglandins  and cytokines,  e.g.  Interleukin (IL -
1β, IL-6) interferon γ and tumor necrosis factor  α (TNFα) (Scholz and Woolf, 2007). These 
mediators excite neurons and aid in the initiation of inflammation via chemoattraction and 
vasodilation. Exogenous administration of such agents (e.g., TNF-α, PGE2)has resulted in pain-
like behavior (Jin and Gereau, 2006;)  Recent studies has shown celecoxib, a COX 2 inhibitor 
reverted oxaliplatin-induced neuropathic pain by inhibition of PI3K/Akt2 pathway in the mouse 
dorsal root ganglion (Jiang et al., 2016).As far as we knew, neuropathic pain is developed as a 
consequence of Neuro inflammatory signaling and central sensitization in the spinal cord 
(Campbell and Meyer, 2006; Ji and Strichartz, 2004; Tsuda et al., 2005). Since psychosocial 
stress is often endured alongside these conditions (Gold et al., 2005; Scadding and Koltzenburg, 
2006; Strang, 1998) and clinical observations suggest that stress increases susceptibility to 
develop pain and exacerbates existing pain (DeLeo, 2006; Greco et al., 2004; Nicholson and 
Martelli, 2004; Turner et al., 2002), it is important to understand how stress affects the 
development and severity of neuropathic pain. 
Accumulating evidence demonstrates that currently available treatment for neuropathic pain, 
such as non-steroid anti-inflammatory drugs, morphine, anti-convulsants and anti-depression 
drugs, has limited efficiency, and is often accompanied by unfavorable side effects.Natural 
products are the most consistently successful sources of drug leads. The screening of natural 
products can provide greater structural diversity than standard synthetic chemistry and offers 
significant opportunities for finding novel low molecular weight lead compounds. With reference 
more than 50 percent of FDA-approved drugs are derived from natural products (Daniel et al., 
2012).Desmodium gangeticum , an Indian medicinal plant has been widely used by many 
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Ayurvedic and Unani physicians for curing fever, cataract, typhoid, piles, bronchitis, dysentery, 
asthma and various other inflammatory conditions arising from ‘vata’ disorder(Subha Rastogi et 
al., 2011) Flavonoid and alkaloid fractions of Desmodium gangeticum were evaluated for anti 
inflammatory and antioxidant activities in carrageenan-induced inflamed rats with the aim of 
studying the promising fraction for inhibitory action on ferrous sulphate induced lipid 
peroxidation, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and 
total reduced glutathione in liver and spleen homogenates of inflamed rats.(Govindaraj et al., 
2007) 
So, in this study Desmodium gangeticumwill be screened for its anti inflammatory and 
neuroprotective activity in invitro and invivo models. Desmodium gangeticum will be screened 
priminarily in LPS intoxicated raw 264.7 model for its anti inflammatory activity. The 
neuroprotective mechanism of action of the Desmodium gangeticum has been evaluated in 
Partial sciatic nerve ligation (PSNL) injury model.  Desmodium gangeticum will also be screened 
for their effect in improving pain associated cognitive impairment. 
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2. LITERATURE REVIEW 
The mechanism underlying neuropathic pain is complex yet it is essential for the perception of 
pain. The onset of neuropathic pain is due to the lesions in the somatosensory system, induced 
either in the peripheral or the central part of the nervous system. This phenomenon that occurs in 
both the peripheral and central nerve is thought to cause the persistence of the chronic 
neuropathic pain (Campbel et al., 2005). Over the years, clinical studies have explored the 
different bases of neuropathic pains from post-surgical cases to diabetics; specifically, divided 
physical causes of pain into two types: nociceptive and neuropathic pain. 
I. NOCICEPTIVE PAIN  
Nociceptors are the nerves which sense and respond to parts of the body which suffer from 
damage. When activated, they transmit pain signals (via the peripheral nerves as well as the 
spinal cord) to the brain. The pain is typically well localized, constant, and often with an aching 
or throbbing quality. Nociceptive pain is mediated by receptors on A-delta and C-fibers which 
are located in skin, bone, connective tissue, muscle and viscera. These receptors serve a 
biological useful role at localizing noxious chemical, thermal and mechanical stimuli. 
Nociceptive pain can be somatic or visceral in nature. Somatic pain tends to be well localized, 
constant pain that is described as sharp, aching, throbbing, or gnawing (Costigan et al., 2009). 
Visceral pain, on the other hand, tends to be vague in distribution, paroxysmal in nature and is 
usually described as deep, aching, squeezing and colicky in nature. Visceral pain is the subtype 
of nociceptive pain that involves the internal organs (Basbaum et al., 2001) Examples of 
nociceptive pain include: post-operative pain, pain associated with trauma, and the chronic pain 
of arthritis. (Richeimer et al., 2010) 
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II. NEUROPATHIC PAIN 
Neuropathic pain, in contrast to nociceptive pain, is described as "burning", "electric", "tingling", 
and "shooting" in nature. It can be continuous or paroxysmal in presentation. Whereas 
nociceptive pain is caused by the stimulation of peripheral of A-delta and C-polymodal pain 
receptors, by algogenic substances (e.g. Histamine bradykinin, substance P, etc.) neuropathic 
pain is produced by damage to, or pathological changes in the peripheral or central nervous 
systems(Dworkin et al. 2003, Woolf & Mannion 1999)Examples of pathological changes include 
prolonged peripheral or central neuronal sensitization, central sensitization related damage to 
nervous system inhibitory functions, and abnormal interactions between the somatic and 
sympathetic nervous systems. (Clin J Pain et al., 2000) The hallmarks of neuropathic pain are 
chronic allodynia and hyperalgesia. Allodynia is defined as pain resulting from a stimulus that 
ordinarily does not elicit a painful response (e.g. Light touch). Hyperalgesia is defined as an 
increased sensitivity to normally painful stimuli. Primary hyperalgesia, caused by sensitization of 
C-fibers, occurs immediately within the area of the injury. Secondary hyperalgesia, caused by 
sensitization of dorsal horn neurons, occurs in the undamaged area surrounding the injury. 
Examples include post herpetic (or post-shingles) neuralgia, reflex sympathetic dystrophy 
causalgia (nerve trauma), components of cancer pain, phantom limb pain, entrapment neuropathy 
(e.g., carpal tunnel syndrome), and peripheral neuropathy (widespread nerve damage). 
(Richeimer et al., 2010) 
III.MIXED CATEGORY PAIN - In some conditions the pain appears to be caused by a 
complex mixture of nociceptive and neuropathic factors. An initial nervous system dysfunction 
or injury may trigger the neural release of inflammatory mediators and subsequent neurogenic 
inflammation. For example, migraine headaches probably represent a mixture of neuropathic and 
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nociceptive pain. Myofascial pain is probably secondary to nociceptive input from the muscles, 
but the abnormal muscle activity may be the result of neuropathic conditions. And remember, 
treating the physical, as well as using the mind's ability to heal itself, will optimize the treatment 
process. Examples of neuropathic pain include: monoradiculopathies, trigeminal neuralgia, post 
herpetic neuralgia, phantom limb pain, complex regional pain syndromes and the various 
peripheral neuropathies. (Steven Richeimer et al., 2010) 
                           
Receptor, neurotransmitters, enzymes, channels: 
Signs of neuropathic pain can be related to the tingling, inching, and burning sensations. The 
locality of the pain is also important indicators to determine the origin and the sprout of the pain, 
usually from the peripheral nerves and then extending to the central nerves. However, these 
sensations of pain can be further analyzed on the molecular basis through signal transduction. 
Some key players involved during pain signaling may include the release of neurotransmitters 
and neuropeptides such as glutamate and substance P; receptors such as the AMPA, NMDA, and 
Glu receptors; the enzymes such as AMP-activated protein kinase activators (Tillu and D.V., 
Price 2012); and the gatekeepers which include the sodium and calcium channels. in addition, 
brain-derived neurotrophic factors (BDNF), nerve growth factors (NGF), and glia-cell derived 
neurtrophic factors (GDNF) also influence neuropathic pain. Neurotrophins, which are usually 
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involved in the development of sensory systems and neuronal plasticity, can mediate and indicate 
the underlying mechanisms of neuropathic pain. Moreover, a number of other neuropeptides 
such as endomorphins, dynorphin A, and galanin can also induce nerve stimulation. The 
modulation and alteration of each player in the signal transduction cascade contribute to the 
primary afferent hyperexcitability; all in all, leading to the perception of 
neuropathicpain.(Campbell et al.,2006) 
             
 
Pre/post – synaptic mechanisms 
The mechanism of neuropathic pain can be first evaluated in the pre- and post- synaptic regions. 
In a normal undamaged neuron, Glutamate, which is an excitatory neurotransmitter, is usually 
restrained by the inhibitory g-protein coupled receptors (i.e. adenosine and GABA-B receptors) 
However, once an injury has occurred on the site of peripheral nerves, anatomical changes can 
take place in excitatory synaptic transmission to up regulate the activity of postsynaptic 
glutamate AMPA receptor-mediated response and the glutamate release. The increased 
glutamate release leads to the amplification of neuronal firing rate and depolarization resulting in 
the sensitization of the nerves to produce pain
. 
(Zieglgänsberge et al., 2005) The upregulation of 
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GluR1 receptors in the post-synapse is a well defined marker for the augmentation of glutamate 
release. The damages to the peripheral sensory neurons consequently affect the central nervous 
system through further release of glutamate, substance P and brain-derived neuropathic factor 
(BDNF) in the primary nociceptor afferent at the central terminal. Substance P binds to the 
neurokinin 1 (NK1) whereas the BDNF binds to the tyrosine kinase receptor (trk) on the post 
synaptic membrane. The gradual depolarization and phosphorylation of the NMDA glutamate 
receptor in the post-synaptic surface is followed by the increase in calcium concentration and 
cAMP subsequently activates the protein kinases C (PKC). Furthermore, the NMDA receptor 
will also stimulate the production of nitric oxide synthetase to promote other excitatory amino 
acid and neuropeptide release from the pain fibers. The overall signalling cascade sensitizes the 
dorsal horn by spontaneous activation and contributes to the modulation of pain. (Tomiyama et 
al., 2005) 
PATHOPHYSIOLOGY 
The mechanisms involved in neuropathic pain are complex and involve both peripheral and 
central pathophysiologic phenomenon. The underlying dysfunction may involve deafferentation 
within the peripheral nervous system (e.g. neuropathy), deafferentation within the central 
nervous system (e.g. post-thalamic stroke) or an imbalance between the two (eg.phantom limb 
pain) ( Cvijanovic et al., 2011) 
PERIPHERAL MECHANISMS:  
Following a peripheral nerve injury (e.g. crush, stretch, or axotomy) sensitization occurs which is 
characterized by spontaneous activity of the neuron, a lowered threshold for activation and 
increased response to a given stimulus. Should the injured nerve be a nociceptor then increased 
nervous discharge will equate to increased pain. Following nerve injury C-fiber nociceptors can 
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develop new adrenergic receptors and sensitivity, which may help to explain the mechanism of 
sympathetically maintained pain. In addition to sensitization following damaged peripheral 
nerves, the formation of ectopic neuronal pacemakers can occur at various sites along the length 
of the nerve. Increased densities of abnormal or dysfunctional sodium channels are thought to be 
the cause of this ectopic activity (Schaible HG et al., 2007). The sodium channels in damaged 
nerves differ pharmacologically and demonstrate different depolarization characteristics.These 
ectopic pacemakers can occur in the proximal stump (eg.neuroma), in the cell bodies of the 
dorsal root ganglion, and in focal areas of demylenation along the axon. Neurogenic 
inflammation is a useful model for understanding pain and hyperalgesia. Neurogenic 
inflammation and the cascade of events following neural injury have been described. 
Inflammatory neuropeptides (substance P) and prostaglandins (PGE2) may be released from 
primary afferent nociceptors and sympathetic postganglionic neurons, respectively, activating 
nearby receptors and triggering a process of spreading activation. These mechanisms may 
explain the clinical response of some neuropathic pain patients to topical nonsteroidal anti-
inflammatory drugs, lidocaine, and capsaicin. (Stephen M. Macres, Steven H. Richeimer and 
Paul J. Duran 2000) 
CENTRAL MECHANISMS:  
Following a peripheral nerve injury, anatomical and Neuro-chemical changes can occur within 
the central nervous system (CNS) that can persist long after the injury has healed. This "CNS 
plasticity" may play an important role in the evolution of chronic, neuropathic pain. As is the 
case in the periphery, sensitization of neurons can occur within the dorsal horn following 
peripheral tissue damage and this is characterized by an increased spontaneous activity of the 
dorsal horn neurons, a decreased threshold and an increased responsivity to afferent input, and 
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cell death in the spinal dorsal horn. In the non-injured state, A beta fibers (large myelinated 
afferents) penetrate the dorsal horn, travel ventrally, and terminate in lamina III and deeper. C 
fibers (small unmyelinated afferents) penetrate directly and generally terminate no deeper than 
lamina II. However, after peripheral nerve injury, there is a prominent sprouting of large 
afferents dorsally from lamina III into laminae I and II.   After peripheral nerve injury, these 
large afferents gain access to spinal regions involved in transmitting high intensity, noxious 
signals, instead of merely encoding low threshold information. Significant alterations have been 
shown in the dorsal horn ipsilateral to the injury. The mechanisms are likely related to the 
barrage of afferent impulses or the factors transported from the lesion site. Therefore, any 
peripheral stimulation would activate a greater number of dorsal horn cells because of an 
increased overlap of their receptive fields. Evidence suggests that excessive nociceptive input to 
the dorsal horn can have excitotoxic consequences resulting in the death of inhibitory 
interneurons. This inhibition may contribute to spinal hyper-excitability. (Macres, et al., 
2000)The allodynia and hyperalgesia associated with neuropathic pain may be best explained by:  
1) The development of spontaneous activity of afferent input  
2) The sprouting of large primary efferents (eg. A-beta fibers from lamina 3 into lamina 1 and  
3) Sprouting of sympathetic efferents into neuromas and dorsal root and ganglion cells,  
4) Elimination of intrinsic modulatory systems and  
5) Up regulation of receptors in the dorsal horn, which mediate excitatory process.  
Pathogenesis of inflammation 
In vivo and in vitro experimental studies have identified biochemical pathways likely to be 
important in the development of inflammatory complications and have led to possible 
approaches to treatment. 
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The most studied mechanisms are 
 TNF- α pathway 
 NO pathway 
 COX pathway 
 Interleukin pathway 
TNF- α:- 
TNF- α known roles have extended from within the immune system to include a neuro-
inflammatory domain in the nervous system Animal models of neuropathic pain based on 
various types of nerve injuries (peripheral versus spinal nerve, ligation versus chronic 
constrictive injury) have persistently implicated a pivotal role for TNF-α at both peripheral and 
central levels of sensitization (lawerence leung et al., 2010) TNF-α plays a role in the peripheral 
mediation of neuropathic pain. Clinically, HIV therapy and chemotherapy produce peripheral 
neuropathy with massive release of TNF-α in serum (Toniniet al., 2002)and TNF-α used as a 
clinical anti-cancer treatment leads to peripheral neuropathy (Droryet al.,1998). Traditional CCI 
of sciatic nerve in rats results in raised levels of TNF immunoreactivity in dorsal root ganglia 
(DRG) of both injured and uninjured ipsilateral adjacent afferents (Geiset al., 2003), as well as 
of contralateral uninjured counterparts (Jancaleket al.,2010), There is also a corresponding up-
regulation of TNFR1 and TNFR2 in both nerve and DRG (Schafers et al.,2003),with a temporal 
pattern of increased TNF mRNA expression, First in sciatic nerve, and then in DRG (Franchi et 
al., 2008). When nucleus pulposus extract of the coccxygeal intervertebral disc is applied to 
lumbar DRG of rats ,neuropathic pain is induced but is abolished by co-application of TNRF1, 
implying a direct role of TNF as a local mediator(Cuellar et al., 2004). Exogenous TNF-α 
injected into DRG of CCI roots is transported both anterograde to the site of injury andretrograde 
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into the dorsal horn (Anterograde et al., 2002), precipitating allodynia in both the ligated and 
adjacent uninjured nerves (Leeet al., 2003). TNF-α is known to lead to apoptosis via TNFR1 
(Thorburn et al., 2003, Micheau et al., 2003) and the caspase signaling pathway (Micheauetal., 
2003). Caspase inhibitors can attenuate peripheral neuropathy experimentally induced byHIV 
therapy or chemotherapy in rats (Joseph et al., 2004). In addition to enhancing TTX-R Na
+
 
channels in nociceptive DRG neurons (Sekiguchi et al., 2009), TNF-α can also increase 
membrane K
+
 ion conductance in a non-voltage-gated fashion (Joseph et al., 2004) leading to  
 
 
                                  Figure 3: Mechanism of TNF-α pathway 
overall neuronal hyper-excitability and hence leading to neuropathic pain.TNF-α has received 
much attention as a culprit in neuropathic pain. Endoneurial administration induces hyperalgesia 
(Wagner and Myers., 1996). Preemptive treatment with the TNF-sequestering drug etanercept 
decreases hyperalgesia but has no effect once hyperalgesia is established (Sommer et al., 2001). 
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TNFα can initiate activity in nociceptors (Sorkin et al., 1997). Inhibition of TNF-α blocks 
phosphorylation of the MAP kinase p38 in DRG and hyperalgesia but again only when given 
preemptively (Schafers et al., 2003). Another cytokine that has received attention is IL-6. A role 
in the CCI model has been suggested (Okamoto et al., 2001) 
Nitric Oxide:- 
Nitric oxide (NO) is a free radical that produces a variety of biological actions under 
physiological and pathological conditions (Tannock IF et al.,2004)and is synthesized by three 
isoforms of NOS: neuronal NOS (nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS) 
(Reid AH  et  al., 2008)Nitric oxide (NO) is a short-living free radical that is produced from L-
arginine by catalytic reaction of inducible NO synthases (iNOSs) within mammalian immune, 
cardiovascular, and neural systems, where it functions as a signalling or cytotoxic molecule and 
it is centrally involved in inflammation (Nathan et al., 1994). Among the three isomer NOSs 
reported to date, endothelial NOS (eNOS, NOS I) and neuronal NOS (nNOS, NOS III) are 
constitutive NOSs, whereas inducible NOS iNOS, NOS II can be induced by immunostimulatory 
cytokines and microbial products in various cell types, including endothelium, smooth muscle 
cells, hepatocytes, monocytes, mast cells, and macrophages (Nathan et al., 1994).Type-I nNOS 
(neuronal NOS) and Type-III eNOS (endothelial NOS) are constitutively expressed as latent 
enzymes and require a higher concentration of Ca2+ for the enzyme activity. In contrast, Type-II 
iNOS (inducible NOS) is Ca2+ independent because s high affinity for Ca2+/Calm (Calmodulin) 
renders the enzyme active even at basal levels of intracellular Ca2+ .The catalysis of this reaction 
require a number of essential cofactors such as mononucleotide, FAD (Flavin Adenine 
Dinucleotide), and NADPH (Nicotinamide Adenine Dinucleotide, Reduced). The NO thus 
generated exerts a number of functions in the cardiovascular system. Their interactions with 
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eNOS are stimulated by intracellular Ca2+ and lead to eNOS activation. Efficient supply with 
substrate during all this is ensured by localization of the arginine transporter CAT1 (Cationic 
Amino Acid Transporter-1) in caveolae and its direct interaction with eNOS.eNOS can interact 
with various proteins in its less active and more active states. Neuronal NOS (nNOS) is localized 
in a discrete population of neurones(Bredt et al., 1991) and is dynamically regulated after 
peripheral inflammation (Herdegen et al., 1994; Wu et al., 1998) Inducible NOS (iNOS) is 
mainly absent in neural tissues under normal conditions, but up-regulated in inflammation 
(Mungrue et al., 2003), for example in astrocytes in the spinal cord dorsal horn (Maihofner et al., 
2000). Endothelial NOS (eNOS) is present in thebrain vasculature (Stanarius et al., 1997) and 
also in astrocytes (Wiencken and Casagrande, 1999). Thus, all three NOS isoforms can act as 
sources of NO in the CNS after inflammation. The non-selective NOS inhibitor N-nitro--arginine 
methyl ester (L-NAME) reducesthermal hyperalgesia in inflammatory pain models (Semos and 
Headley, 1994; Osborne and Coderre,1999), indicating a role of NO in inflammatory pain. 
Furthermore, several reports indicated beneficial effects of selective blockers for nNOS and 
eNOS in reducing inflammatory and neuropathic pain,  
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COX pathway:- 
The arachidonic acid pathway is responsible for the generation of a wide variety of bio active 
metabolites. These metabolites, otherwise known as eicosanoids, have been shown to be 
involved in many different pathology, including inflammation. Arachidonic acid can be 
metabolized into the biologically active eicosanoids via the action of three separate groups of 
enzymes: cyclooxygenases (COX) also known as prostaglandin (PG) H synthase, lipoxygenases 
(LOX), and epoxygenases (cytochrome P450). The COX enzymes catalyse the first step in the 
synthesis of prostanoids from arachidonic acid (Wang et al., 2010). COX was shown to exist as 
two distinct isoforms in the early 1990s. These included the constitutively expressed COX-1 and 
the inducible form of COX-2, associated with inflammation (Warner et al., 2004). A third COX 
isoform has also been identified, known as COX-3 (Chandrasekharan et al., 2002). However, 
subsequent studies have shown that it has no COX activity and is therefore unlikely to have 
prostaglandin producing activity in human tissue (Snipes et al., 2005).  
Interleukin:- 
The interplay between the immune and nervous systems is thought to be critical for the 
development and maintenance of neuropathic pain, and the proinflammatory cytokines, including 
IL-1β, appear to be contributing to the pain state ( Scholz and Woolf et al., 2007, and Uceyler 
and Sommer et al., 2008). In various animal models of neuropathic pain, IL-1βexpression is 
increased in the injured sciatic nerve, DRG, and spinal cord (Rotshenker et al.,1992;Hashizume 
et al., 2000, Lee et al., 2004; Perrin et al., 2005; Ruohonen et al., 2005;Uceyler et al., 2007; 
Kawasaki et al., 2008a).Immediately after peripheral nerve injury, Schwann cells are activated 
and macrophages are recruited to the injury site and both secrete IL-1β (reviewed in Scholz and 
Woolfet al., 2007).In a rat transected sciatic nerve model, upregulation of IL-1β has been 
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detected as long as 35 days post-surgery (Ruohonenet al.,2005). Recently, new mechanisms of 
neuropathic pain have been revealed involving a complex pathway with MMP9, MMP2 and IL-
1β. Kawasaki et al., 2008ashowed that in the PSNL model cleavage of IL-1β by MMP subtypes 
contributed to different phases of neuropathic pain behavior. Therefore, IL-1β is likely part of a 
complex signaling cascade involving MMPs in the CCI model. Nerve injury increases expression 
and secretion of proinflammatory cytokines, including IL-1β, IL-6, and interferon-γ, all of which 
are required for the development of pain hypersensitivity (Murphy et al., 1995; Costigan et al., 
2009). Interleukin-6 is an inflammatory cytokine with wide-ranging biological effects. It has 
been widely demonstrated that neuro inflammation plays a critical role in the development of 
pathological pain. Recently, various pathological pain models have shown elevated expression 
levels of interleukin-6 and its receptor in the spinal cord and dorsal root ganglia. This 
sensitization triggers the production of mediators, alteration of ion channels, and sprouting of 
nerveendings.                                    
 
Many evidences have indicated that IL-6 plays a critical role in neuropathic pain caused by 
PSNL induced peripheral neuropathic pain. IL-1 is particularly known to modulate pain 
sensitivity. IL-1 has also been implicated in the development of neuropathic pain. Elevated levels 
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of IL-1 were detected following peripheral nerve injury (DeLeo et al., 1997; Rotshenker et al., 
1992; Shamashet et al., 2002). peripheral hyperalgesic effects of IL-1 could be mediated directly 
by exciting nociceptive fibers, or indirectly by stimulating the production of pronociceptive 
compounds, such as nitric oxide (NO), prostaglandins, and nerve growth factor (NGF), or the 
release of calcitonin gene related peptide (CGRP) (Marchand et al., 2005) 
CHRONIC PAIN AND MEMORY 
To understand the connection between chronic pain and memory problems or other forms of 
cognitive problems, this fact is that the experience of pain occurs because of our brain and other 
parts of our nervous system. Whatever the initial cause of pain, once the pain becomes chronic; it 
becomes a nervous system problem. Different areas of the nervous system, such as in the brain 
and spinal cord, go through changes and these changes are responsible for the development of 
chronic pain. One area of the brain that appears to go through such changes is the hippocampus 
(Cardoso-Cruz, Lima, & Galhardo et al., 2013; Mutso, et al., 2013). The hippocampus is 
involved in the development of central sensitization (Lamtremoliere & Woolf, 2009), depression 
(Campbell & MacQueen, 2004), and memory (Squire, 1992). Pain can change the hippocampus. 
In turn, these changes to the hippocampus can create a cascading effect on the experience of 
pain, leading to central sensitization, depression, and memory problems. Much is yet to be 
learned from the study of chronic pain and the nervous system. The hippocampus may not be the 
only thing that is responsible for the development of memory problems in people with chronic 
pain.  
Animal models of neuropathic pain:- 
Animal models are pivotal for understanding the mechanism of neuropathic pain and 
development of effective therapy for its optimal management. A battery of neuropathic pain 
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models has been developed to simulate the clinical pain conditions with diverse etiology. As 
each animal model has been created with specific methodology and results tend to vary largely 
with the slight changes related to methodology, therefore, it is essential that data from different 
models should be reported and interpreted in the context of the specific pain model 
 (Jaggi  et al., 2011) 
Partial sciatic nerve ligation 
Partial nerve injury is the main cause of causalgic form pain disorders in humans. Here present 
here a novel animal model of this condition. In rats we unilaterally ligated about half of the 
sciatic nerve high in the thigh. In this model, the left hind leg of a rat is shaved and dissection is 
made to expose the sciatic nerve at the upper-thigh level. The dorsal one-third to half of the 
sciatic nerve is tightly ligated with an 8–0 silk suture just distal to the point at which posterior 
biceps semitendinosus nerve branches off. The behavioral signs of spontaneous pain in the form 
of paw guarding and licking on the injury side have been reported. The behavioral alterations 
like cold allodynia, chemical hyper-reactivity, and mechanical hyperalgesia have been noted to 
occur within 1 week after the surgery and most of the changes persist for 6 weeks PSNL model 
represents sympathetically independent pain (SIP) in the first week post-operation. (Dowdall et 
al., 2005.Within a few hours after the operation, and for several months thereafter, the rats 
developed guarding behavior of the ipsilateral hind paw and licked it often, suggesting the 
possibility of spontaneous pain,(seltzer et al., 1990) The plantar surface of the foot was evenly 
hyperesthetic to non-noxious and noxious stimuli.. The partial nerve injury models are relevant 
for understanding neuropathic pain injury, as the partial nerve injury is the main cause of 
causalgic form pain disorders in humans. (Seltzer et al., 1995) Because of the immediate onset 
and long-lasting continuation of touch-evoked allodynia and hyperalgesia (parallel to the pain in 
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humans with causalgia), it has been suggested that PSNL model is a good animal model for 
causalgic form pain syndromes (Malmberg et al., 1998) 
                  
Behavior models for neuropathic pain and memory: 
The hot-plate test is useful for evaluating acute pain. The hot plate test involves two types of 
responses: paw licking and jumping. Both responses integrate at supraspinal structures with the 
C and A-delta type I and II sensitive fibers participating in this model (Lopes et al., 2009). The 
nociceptive withdrawal threshold was assessed by using the Randall-Selitto electronic 
algesimeter. The Randall-Selitto test appears to be a useful method for studying neuropathic pain 
conditions affecting both the fore- and hind limbs, and thus responses corresponding to above 
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and below the segmental level of the lesion. Central sensitization, providing a mechanistic 
explanation for how low threshold A or C fibers can begin to transmit pain, has been generally 
accepted (Chu et al., 2008).This commercially available instrument (electronic von Frey) is 
similar to that successfully used to quantify neuropathic allodynia (Bach et al., 1994) and 
inflammatory hyper nociception in rats (Li et al., 1998). Performance on this task is assessed by 
measuring the animal's latency to enter the goal box at the end of the beam. The assessment of 
motor function with the beam-balance and beam-walking tasks have been the primary dependent 
variable in the study of the neuro pharmacologic mechanisms of peripheral injury (Hayes et 
al.,1988; Lyeth et al.,1988). The rotarod task, first developed by Dunham and Miya (1957), is a 
frequently used screening test for evaluating neurologic effects of various drugs. As originally 
used, the procedure required the rat to maintain its equilibrium on a rod that rotated at a constant 
speed. Jones and Roberts (1968) increased the sensitivity of the task by gradually\ increasing the 
speed that the rod rotated while the animal was walking on the rod. Several reports have 
investigated the effects of CNS depressants on rotarod performance and have found the device to 
be a useful tool for evaluating motor function (Kuribar et al.,1977).However, the rota rod task 
has not been explored as a potential instrument for identifying motor deficits following by 
peripheral injury Morris water-maze performance involves several components, including 
concept formation (learning the general rules of the task), attention, working memory, and 
reference memory, which are not readily distinguishable in a simple form of this paradigm 
(Morris,1989; Whishaw, 1989; Bannerman et al., 1995). Thus, we used several variants of the 
Morris water-maze in an effort to deter- mine whether the rat lines differed in their associative 
abilities, conceptual abilities, working and reference memory. Search strategies, and native 
attention distractibility. The novel object recognition task has been widely used for studies on 
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interferences in the recognition memory (Ennaceur and Delacour, 1988). The task is based on the 
spontaneous behavior of the animals to explore more a novel object than a familiar one. Thus, 
this task has been widely used to assess normal physiological events as well as genetic and 
pharmacological interventions in the recognition memory process (Chuhan and Taukulis, 2006; 
de Bruin and Pouzet, 2006; Palchykova et al., 2006). 
Plant profile 
Desmodiumgangeticum (Shalparni) is a 2-4 feet high erect under shrub with woody stem, 
branches covered with soft hairs. It is found in the forest and waste lands of India, from the 
plains and Western Ghats, and up to 1500 m in the north up to Sikkim and also in south India. 
Shalaparniplant leaves are unifoliate, ovate, oblong, obtuse, and pubescent beneath and up to 15 
* 8 cm long. Its inflorescence is many flowered, terminal or auxiliary, slender and 15-30 cm 
long. The flowers are small and of pink-violet colour. Pods are thin, pointed, 1.5 to 2 cm long 
clothed with minute hooked hairs. Flowering and fruiting occur in the month of August and 
November. (Subha Rastogi et al., 2011) 
Scientific Classification 
The botanical name of is Desmodiumgangeticum (L.) DC. It belongs to plant family Fabaceae. 
Fabaceae, is also known as Leguminosae or pea family and consists of about 20,000 species of 
plants, including trees, shrubs, vines, and herbs distributed all across the world. The fruits are 
present inside a legume or seed pod. (Yadav et al., 2013) 
Constituents of Desmodium gangeticum 
The roots contain several alkaloids, flavonoids, pterocarpanoids— gangetin (gives 
antiinflammatory activity), gangetinin, and desmodin. The aerial parts contain indole-3-
alkylamines and their derivatives. (Shri Vijaya Kirubha et al., 2011) 
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Ayurvedic Properties and Action of  Desmodiumgangeticum:- 
The root of the plant is astringent, bitter and sweet in taste (Rasa), sweet after digestion (Vipaka), 
and is hot in effect (Virya).It is an Ushna Virya herb. UshnaVirya or hot potency herb, subdues 
Vata (Wind) and Kapha (Mucus) and increases Pitta (Bile). It has a property of digestion, 
vomiting and purging, and gives a feeling of lightness.(Pantulu et al., 1948) 
Important Medicinal Properties 
Desmodiumgangeticum is rich in medicinal properties. The understanding of these properties 
will help us to better utilize this herb.The medicinal plant Shalparni or Sarivan 
(Desmodiumgangeticum) is extensively used in Ayurveda. It is one of the ten roots of famous 
anti-inflammatory formulation of Ayurveda, Dashmula. Dashmula has been used since time 
immemorial to treat swelling inside body and intake of Dashmula balances Vata and Kapha, 
digests the ama and gives relief in pain. For medicinal use purpose whole plant is used. (Sagar et 
al.,2010) 
Below is given medicinal properties along with the meaning, (Rastogi et al., 2011) 
Antioxidant: neutralize the oxidant effect of free radicals and other substances. 
Anti–inflammatory: reducing inflammation by acting on body mechanisms. 
Anti–nociceptive: inhibits nociception, the sensation of pain. 
Anti–rheumatic: alleviating or preventing rheumatism. 
Anti–osteoarthritic: Against Osteoarthritis. 
Astringent: causing the contraction of body tissues. 
Antipyretic / antifebrile / febrifuge: Effective against fever. 
Anthelmintic: anti-parasitic, expel parasitic worms (helminths) and other internal parasites from 
the body. 
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Diuretic: Promoting excretion of urine/agent that increases the amount of urine excreted. 
Immunostimulant: stimulate the immune system by inducing activation or increasing activity of 
any of its components. (Suman singh et al., 2016) 
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3. PLAN OF STUDY 
SPECIFIC OBJECTIVE 
 
 To prepare Desmodium gangeticum aqueous extract and to quantify the chemical 
constituents through HPTLC fingerprinting study.
 
 
 To assess  the effect of  Desmodium gangeticum  in LPS induced inflammation in  
RAW 264.7 (Murine macrophage) cell lines. 
 
 To find the activity of the Desmodium gangeticum extract on mechanically induced 
Pain and cognitive impairment in partial sciatic nerve ligation rat model. 
 
 To find the mechanism of action of  Desmodium gangeticum extract by measuring 
inflammatory markers in sciatic nerve and brain  through conventional PCR , ELISA 
and histopathological studies also been done to support the research findings. 
 
 
PHAES: I 
Extraction of the Herb 
 Aqueous extract preparation through water decoction 
 Qualitative analysis by chemical test 
 Quantification of chemical constituents by HPTLC 
PHAES: II 
In-vitro Studies 
 Dose Optimization of DG extract as well as LPS by MTT assay 
and the effect of DG Extract towards LPS induced toxicity by co-
administering LPS and DG extract.  
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PHAES: III 
PSNL Surgery 
 
 Partial Sciatic Nerve Ligation was done in rats to induce 
neuropathic pain through mechanically in rats, Treatment was 
continued up to 28
th
 day and general observation was done on 7
th
, 
14th, 21st
 
& 28
th
 day using behavioral test models such as 
thermal, mechanical, chemical induced pain model, cognitive 
functions in rats was recorded by performing Morris water maze 
and novel object recognition tests. 
PHAES: IV 
Measurement of pro-inflammatory mediators & Histopathology studies 
 
 At 28
th
 day sciatic nerve was isolated for histopathological 
studies and measuring pro-inflammatory mediators responsible 
for neuropathic pain like TNF-α, IL-1β, IL-6, e-NOS and COX 
were measured through PCR and ELISA studies. 
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4. MATERIALS AND METHODS 
 
4.1 Chemicals and Instruments Used 
 
The chemicals used for the present study were tabulated. 
Table 1: List of chemicals used 
 Chemicals Manufacturer  
    
    
 Ketamine  Med India  
    
 Xylenol  Kruz Pharma  
 Carboxy Methyl Cellulose  OTTO  
 Toluene RANKEM  
    
 HPTLC Plates Merck  
    
 Millipore water Direct-Q  
    
 Lipopolysaccharide Sigma Aldrich  
    
 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide Sigma Aldrich  
    
 Dimethyl sulphoxide Fisher Scientific  
    
 PCR KIT HI-MEDIA  
    
 ELISA LIT HI-MEDIA  
    
 Ethylenediamine tetra acetic acid HI-MEDIA  
    
 Gabapentin Sun Pharma  
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                                          Table 2: List of instruments used 
Instrument Manufacturer 
  
Laminar Airflow AIRSYS 
  
Inverted Trinocular Phase contrast Microscope Motic 
  
CO2 Incubator SANYO 
  
Refrigerated centrifuge Eppendrof 
  
Deep freezer Cryo scientific systems 
  
Autoclave Sterilizer Everflow scientific 
  
UV-Visible spectrophotometer Schimadzu 
  
Vortex TARSONS 
  
PCR Thermo Scientific 
  
HPTLC CAMAG 
  
  
  ELISA READER  Thermo Scientific 
 
4.2 Animals 
 
Adult female Sprague Dawley rats (200-250g) were obtained from the animal house of PSG 
IMS&R, Coimbatore. The rats were grouped and housed in polypropylene cages (38 X 23 X 
10cm) with not more than 6 animals per cage. They were maintained at an ambient temperature 
of 25+1°C. Animals had free access to food and water. The animals were acclimatized to 
laboratory condition for one week prior to experiments. The experimental protocols were 
approved by Institutional Animal Ethics Committee and conducted according to the guidelines of 
the Committee for the Purpose of Supervision and Control of Experiments on Animals 
(CPCSEA), Government of India. 
MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACOLOGY, PSG COLLEGE OF PHARMACY. Page 32  
  
 
4.3 Desmodium gangeticum Water Decoction Extract 
In this Desmodium gangeticum aqueous extract prepared by water decoction method as per 
Ayurvedic principle.The shade-dried root and aerial parts were powdered and passed through 10-
mesh sieve. The coarsely powdered materials (1000 g) were soaked in distilled water in the ratio 
of 1:16 (w/v). The extracts were filtered, pooled and first concentrated on rota vapour and then 
dried in freeze dry system/Freezone® 4.5 with high vacuum, at −40 ◦C (yield 14.1% root and 
16.7% (w/w) aerial parts of dried extract). The chemical constituents of the root and aerial 
decoction were identified by qualitative analysis and confirmed by thin layer chromatography 
(Trease and Evans, 1983). This indicates the presence of alkaloids and flavonoids. For the 
pharmacological tests, the dried extract of root and aerial parts of Desmodium gangeticum was 
suspended in double distilled water containing 1% (w/v) carboxymethyl cellulose (CMC) and 
were used throughout our experimental studies. 
4.3.1 Qualitative Chemical Tests 
Test for alkaloids:-  
Mayer’s test 
Extracts or fractions were treated with Mayer’s reagent (Potassium-mercuric Iodide), appearance 
of cream colored ppt. confirmed alkaloids. 
Wagner’s test  
Extracts or fractions were treated with Wagner’s reagent  (Iodine in potassium iodide solution), 
when appearance of reddish brown ppt. confirmed alkaloids.  
Dragendorff’s test 
Extracts or fractions were treated with Dragendorff’s  reagent  (Solution of Potassium Bismuth 
Iodide), when appearance of reddish brown ppt. confirmed alkaloids. 
Test for Carbohydrates:- 
Molisch’s test  
Extracts or fractions were treated with α-naphthol followed by addition of Conc. Sulphuric acid, 
when appearance of purple colour confirmed the presence of carbohydrates.  
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Benedict’s test 
Extracts or fractions were treated with Benedict Reagent  
(173gm sod. Citrate + 100gm sod. Carbonate + 17.3gm copper sulphate) followed by boiling for 
2 min then allowed to cool, when appearance of red, yellow or green ppt. depending on amount 
of sugar confirmed the presence of carbohydrates.  
 
Tests for Flavonoids and Coumarins:-  
Mineral acid test  
Extracts or fractions were treated with Conc. Sulphuric acid, when appearance of yellow orange 
colour confirmed the presence of Flavonoids.  
Sodium Hydroxide test  
Extracts or fractions were treated with 10% sod. Hydroxide solution, when appearance of yellow 
orange colour confirmed the presence of Flavonoids. 
 
Test for steroids:- 
Libermann-Burchard Sterol reaction  
To the extracts or fractions glacial acetic acid was added followed by addition of conc. Sulphuric 
acid, when a colour change from rose, through red, violet and blue to green confirmed the 
presence of steroids.  
Salkowski reaction  
To the extracts or fractions chloroform was added followed by addition of conc. Sulphuric acid, 
when appearance of red colour in chloroform layer confirmed the presence of steroids.  
 
Test for triterpenoids 
Hirchorn test  
To the extracts or fractions Trichloroacetic acid was added followed by warming, when 
appearance of yellow to red colour confirmed the presence of triterpenoids.  
Salkowski reaction  
To the extract or fractions chloroform was added followed by addition of conc. Sulphuric acid, 
when appearance of red colour in chloroform layer confirmed the presence of triterpenoids.  
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Test for tannins  
Ferric chloride test  
To the extracts or fractions freshly prepared Ferric chloride solution was added, when 
appearance of blue-black or brownish colour confirmed the presence of tannins. 
4.3.2 HPTLC finger printing 
The samples were spotted in the form of bands of width 6 mm with a CAMAG microlitre 
syringe on precoated silica gel aluminium plate 60 F–254, (10 cm × 10 cm with 250 µm) 
thickness; E. Merck, Darmstadt, Germany, supplied by Anchrom Technologists, Mumbai. By 
using a CAMAG Linomat IV(Switzerland). The plates were prewashed by methanol and 
activated at 60°C for 5 min prior to chromatography. A constant application rate of  0.1 µl/sec 
was employed and space between two bands was 5 mm. The slit dimension was kept at 5 mm × 
0.45 mm and 10 mm/sec scanning speed was employed. The monochromatic band width was set 
at 20 nm, each track was scanned thrice and baseline correction was used. The mobile phase 
consisted of (Ethyl acetate: glacial acetic acid: Formic acid water (100:11:11:26) and 15 ml of 
mobile phase was used per chromatography. Linear ascending development was carried out in 
10 cm × 10 cm twin trough glass chamber (CAMAG, Muttenz, Switzerland) saturated with the 
mobile phase and the chromatographic plate development was carried out for two times with the 
same mobile phase. The optimized chamber saturation time for mobile phase was 1hr at room 
temperature (25 ± 2 °C) at relative humidity of 60 ± 5%. The length of chromatogram run was 8 
cm. Subsequent to the development, HPTLC plates were dried in a current of air with the help of 
an air dryer. Densitometric scanning was performed on CAMAG TLC scanner III in the 
reflectance-absorbance mode at 366 nm and operated by CATS software (V 3.15, CAMAG). 
The source of radiation utilized was deuterium lamp emitting a continuous UV spectrum 
between 190 and 400 nm. Concentrations of the compound chromatographed were determined 
from the intensity of diffusely reflected light. Evaluation was via peak areas with linear 
regression. (Himani Agrawal et al., 2004). 
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Chromatographic condition 
Stationary phase : Silica Gel GF254 
             Mobile phase : Ethyl acetate: glacial acetic acid: Formic acid       
water(100:11:11:26) 
Chamber saturation time : 1 hr 
  Instrument : HPTLC (CAMAG-version 1.3.4, USA) 
  Applicator : Linomat V 
  Scanner : CAMAG TLC Scanner 
  Developing mode     :  Ascending mode (multiple development) 
Detection reagent : Dragendorff’s reagent 
Scanning wavelength : 254, 366 nm 
Experimental condition : 25±2˚C Temp/RH: 55-65% 
4.4In vitro studies 
4.4.1 Mammalian cell culture 
RAW 264.7 (Murine macrophage cell line) was obtained from NCCS Pune. It was maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% serum(FBS), 
amphotericin (3 µg/ml), gentamycin (400 µg/ml), streptomycin(250 µg/ml) and penicillin (250 
units/ml) at 37°C in a carbon dioxide incubator at 5% CO2. 
4.4.2 Preparation of media and other reagents required for cell culture 
4.4.2.1 Minimum Essential Medium (MEM) was prepared as follows 
The powdered media was dissolved in 900 ml of sterile glass - distilled or Millipore water in an 
autoclaved glass conical flask under sterile conditions. The antibiotics were added in the 
concentration as mentioned above and stirred well. 3.7 g of Sodium bicarbonate was added into 
the flask and stirred until it gets dissolved completely. 10% FBS was added and mixed well. The 
liquid was slowly poured into the upper portion of a Media sterilisation unit (Corning) and 
filtered through a 0.2µ filter under negative pressure. The medium was immediately stored at 
4
o
C. 
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4.4.2.2 Saline: Trypsin: Versene (STV) 
10X Saline A: 8g NaCl, 0.4g KCl, 1.0g D-Glucose and 0.35g NaHCO3 (Tissue Culture Grade) 
were dissolved in 100 ml water and stored at 4
o
C. Versene: 1g EDTA (Tissue Culture grade) 
was added into 90 ml distilled water. Then 5N NaOH was added drop wise until it gets 
dissolved. The solution was filter sterilized and stored at 4
o
C. 100 ml of STV was prepared by 
adding 25 mg of trypsin in a mixture of 10 ml of 10X Saline A and 2.5 ml of Versene Double 
distilled water was added to make up to 100 ml, sterile filtered, liquated, and frozen at –20
o
C to 
–70
o
C. 
 4.4.2.3Maintenance and storage of cell lines 
RAW 264.7 cells show a steady growth rate with a doubling time of 36 to 48 hrs. The cells 
reached confluence in 6 to 7 days and these cells were passaged to get the cells for the 
experiments and also to store in liquid nitrogen. Passaging was done as follows:The culture 
medium was removed from the 25 ml culture flask by decanting into a clean container inside the 
laminar airflow chamber, and cells were rinsed with medium without serum, to remove traces of 
serum, which may inhibit action of trypsin. 2 ml of STV solution was added to the flask 
containing cells and incubated at 37
o
C for a few minutes. As soon as cells started dislocating 
from the surface, flask was rinsed with 5ml of serum-containing medium to arrest the 
trypsinisation. The suspension of cells was collected in a sterile 15 ml centrifuge tube and the 
cells were pelleted at 1500rpm for 3 minutes. The cell pellet was resuspended in fresh medium 
with serum and a part of the cells were seeded back into the flask. The remaining cells were used 
for experiment or pelleted as earlier and resuspended in cryopreservative medium (10% DMSO 
in serum) in a cryovial (Nunc) and frozen at -70
o
C for a day then transferred to liquid nitrogen. 
4.4.4 Drugs and LPS Preparation 
Extracts were subjected to solubility test with different organic solvents, finally get dissolved in 
dimethyl sulphoxide (DMSO), 25 mg/100 µl stock was prepared. The desired doses such as of 
0.01 to 0.5µg/ml were prepared from the stock using culture medium. Lipopolysaccharide (LPS) 
in the dose of 1mg/ml was prepared with distilled water. 
MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACOLOGY, PSG COLLEGE OF PHARMACY. Page 37  
  
 
4.4.5 MTT assay 
RAW 264.7 cell lines were maintained in Minimum Essential Medium (MEM) supplemented 
with 10% serum (FBS), amphotericin (3µg /ml), gentamycin (400µg/ml), streptomycin (250 µg 
/ml) and penicillin (250 units/ml) in a carbon dioxide incubator at 5% CO2. 5000-10000 
cells/well were added in 96 well plates from well grown culture medium, the viability was tested 
using trypan blue dye with help of haemocytometer and 95% of viability was confirmed. After 
24 hrs, the LPS (1- 400µg/ml) were incubated with Cultured RAW cell lines separately for 24 
hrs. After incubation, the LPS containing medium was removed and the medium was changed 
again for all groups and 10 μl of MTT (5 mg/ml stock solution) was added and the plates were 
incubated for an additional 4 hrs. The medium was discarded and the formazan blue, which was 
formed in the cells, was dissolved with 150 μl of DMSO. The optical density was measured at 
595 nm. The percentage toxicity was calculated by using following formula 
 
% Toxicity = (LPS treated cells/LPS untreated cells) x 100 
In vivo studies 
Table 3: Treatment schedule 
 
GROUP TREATMENT 
NUMBER OF 
ANIMALS   
   
Group-I Sham control 6 
   
Group-II Negative control 6 
   
Group-III Standard control (gabapentin 30mg/kg) 6 
   
Group-IV PSNL+ Desmodium gangeticum (25mg/kg, p.o.) 6 
   
Group-V    PSNL+ Desmodium gangeticum (50mg/kg, p.o.) 6 
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4.5 PSNL Induction for rats:- 
The animals were divided into five groups.1
st
 group is designated as grouped as sham operated 
(rats were underwent surgical procedure without nerve ligation) and other rats from remaining 
group underwent partial sciatic nerve ligation. Treatment was started after 24hrs of the surgery 
with gabapentin (30mg/kg), Desmodium gangeticum extract (25 & 50mg/kg), up to 28 days. The 
drug effect was observed on 7
th
 and 28
th
 day using thermal, mechanical and chemical induced 
pain assessment and also other cognitive function tests. 
4.5.1 Partial Sciatic Nerve Ligation Model: 
Peripheral neuropathic pain after partial sciatic nerve ligation was induced in SD rats (female) 
using a similar procedure to that described by Seltzer et al. for rats. Rats were anesthetized with 
xylazine (50mg/kg) and ketamine (120 mg/kg) (intraperitoneal) Unilateral mono neuropathy was 
induced by a rigid side ligation on one side exposed by making a skin incision, and cutting 
through the connective tissue between the gluteus superficialis and biceps femoris muscles of 
about one- third to one-half of the left sciatic nerve (ipsilateral) diameter performed with 8–0 silk 
suture. To just occlude but not arrest epineural blood flow. The wound is closed with sutures in 
the muscle and staples in the skin.. The ligatures were loosely tied until a short flick of the 
ipsilateral hind limbwas observed. The animal is then allowed to recover from surgery for 24 hrs 
before pain hypersensitivity testing begins. However the recovery time may vary from 2
nd
 day to 
2 weeks time as the intensity of pain lasts for about 3 weeks or one month time according to 
various studies. The best time for the pain hypersensitivity testing is found to be testing the 
subject in periodic intervals starting from 7
th
 day, up to the 28
th
 day postoperative as during this 
time the hypersensitivity reaches the peak with a previous testing of half an hour prior to the 
surgery and 2 days before surgery. The size of the nerve to be freed from adhering tissues is 7 
mm. So, that the length of the nerve tied with ligatures and affected will be 4-5 mm long. The 
dosing of the rats with the test drug will be done after 24 hours of recovery from surgery which 
may continue till maximum 28 days after which the ligated sciatic nerve and other required 
tissues will be isolated from the sacrificed rat and will be subjected for histopathology analysis 
and other estimation studies (seltzer et al., 1990). 
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4.5.2 Hot plate method (THERMAL HYPERALGESIA): 
In this test, the animals were individually placed on a hot plate (Eddy’s hot plate) with the 
temperature adjusted to 55_1 _C. The latency to the first sign of paw licking or jump response to 
avoid the heat was taken as an index of the pain threshold; the cut-off time was 10 s in order to 
avoid damage to the paw (Tiwari et al., 2011) 
4.5.3 Randell-sellito method (MECHANICAL HYPERALGESIA): 
This paw pressure test was conducted according to the method described by Woode et al 72 and 
Zakaria et al 73. The rats were placed on the Ugo Basile dynamic plantar aesthesiometer for 20 
minutes prior to the experiment to enable them to adapt to their surroundings constant force of 20 
g/s was applied to the injected paw with cutoff time at 30 seconds, and the response time for 
nociceptive behavior (withdrawal of the injected paw) was recorded . 
4.5.4 Von-frey filaments (MECHANICAL ALLODYNIA): 
To measure mechanical thresholds, the electronic Von Frey method was used. Rats were first 
weighed on a scale before being placed in separate plexiglass boxes on top of a raised wire mesh. 
They were left to acclimate for approximately 30 minutes prior to testing. Stimulation of the 
lateral area of the hind paws was done using the 90 g arm and the size 8 filament. The maximum 
threshold readout that accompanied a paw flick was recorded. Both paws of each animal were 
stimulated three times, with 2-minute rest in-between stimulations. 
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4.5.5 COGNITIVE BEHAVIOURAL MODELS: 
4.5.5.1 MORRIS WATER MAZE: 
Morris water maze employed in the present study was a model to evaluate spatial learning and 
memory (118). It consisted of large circular pool (150 cm in diameter, 45 cm in height, filled to a 
depth of 30 cm with water maintained at 28±1
o
C). During the MWM test, a platform 15 cm in 
diameter was located 1.5 cm below the water in one of four sections of the pool, approximately 
50 cm from the sidewalls. The pool was divided into four quadrants of equal area. A camera was 
mounted to the ceiling above the pool and the paths taken by the rats were recorded.  
Acquisition phase 
The MWM test was initiated on the 3
rd
 day after gabapentin administration had started. The 
animals received four trials per day. The rats were trained to find the hidden platform. The 
position of platform was kept unaltered throughout the training session. Each animal was 
subjected to four consecutive training trials on each day. The rat was gently placed in the water 
between quadrants, facing the wall of pool and allowed 60 sec to locate submerged platform. 
Then, it was allowed to stay on the platform for 20 sec. If it failed to find the platform within 60 
sec, it was guided gently onto platform and allowed to remain there for 20 sec. Day 6 escape 
latency time (ELT) to locate the hidden platform in water maze was noted as an index of 
acquisition or learning. Animals were subjected to training trials for six consecutive days.  
Between one trail and the next, water was stirred to erase olfactory traces of previous swim 
patterns.  
Retention phase 
On ninth day, the platform was removed and each rat was allowed to explore the pool for 90 sec. 
Mean time spent in the target quadrants was noted. The mean time spent by the animal in target 
quadrant searching for the hidden platform was noted as an index of retrieval or memory.  The 
time to reach the target quadrant and the number of crossings the animal made while searching 
the target quadrant was also noted as index of memory. 
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4.5.5.2 Novel-object recognition test 
The novel-object recognition test procedure Testing was carried out in a circular arena with a 
wooden base and metal sides (both painted black), with dimensions 75 cm (d) ×38 cm (h). The 
arena was illuminated by four 60 W bulbs which provided constant light intensity of 100 lx. The 
objects used were with a base diameter of 4.5 cm and 23.5 cm height and a plastic structure 
constructed from green and pink toy blocks with dimensions base area 5 cm2 and height 16 cm. 
The objects had no apparent natural significance to the rats, and were secured to the base of the 
arena with white tack such that they were difficult to displace. Animals were habituated to the 
arena in the absence of objects for 20 min on the day before the test day.  
The test day comprised of three stages: 
(i) Habituation, (ii) exposure one and (iii) exposure Two 
 Rats were introduced to the arena for a 3 min habituation period and then returned to their home 
cage for 7 min. During exposure 1, two identical objects were placed in opposite quadrants of the 
arena, 16 cm from the perimeter. The rat was allowed to freely explore the arena and objects for 
a period of 3 min, after which the animal was removed from the arena and returned to its home 
cage for an interval of 5 min. prior to exposure 2, one of the object was replaced with a novel 
object.  
The animal was again allowed to freely explore the arena and objects for a period of 3 min and 
then returned to its home cage. The arena was cleaned with a mild detergent between rats to 
remove odours and olfactory cues, and fecal pellets were removed between exposures. 
Exploration of an object was defined as sniffing the object, rearing against the object or having 
the head directed towards the object within a 2 cm annulus of the object. Exploratory and general 
behaviors were manually rated of each of the three test stages, the proportion of time spent 
exploring the object was assessed by calculating a discrimination ratio as follows: 
Assessments; 
An inspection is operationally defined as approaching, sniffing and looking at object from  a 
distance of  2cm 
Habituation 
Time taken to initially enter the innerzone time spent in centrezone 
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Training 
Time taken to initially enter and inspect the objects time taken inspecting each object 
Time spent in center zone 
Testing 
Time taken to initially enter and inspect the objects Time taken inspecting each object  
(50% of time inspecting the familiar suggests memory deficit)  
Entries into centre 
Note; sitting on object not considered an inspection 
Percent time inspecting; TF/TN+TF*100 
[TF=spent exploring familiar object; TN=time spentexploring the novel object] 
4.6 Conventional PCR: 
Total RNA was isolated by Trizol method as per manufacturer protocol. The pellet was washed 
once with 75% ethanol centrifuged again for 5 min, air-dried and dissolved in 50 μlDEPC treated 
water. Total RNA was stored at -80ºC. 1µg of RNA was using Enhanced Avian C-DNA Kit 
(Sigma Aldrich,USA). After initial denaturation for 10 min at 95°C, thirty five amplification 
cycles were performed for TNF-α (30s of 95 °C denaturation,1 min of 60 °C annealing and 
extension), IL1β (15s of 95 °C denaturation, 1 min of 60 °C annealing and extension. 
4.7 ELISA: 
Rat TNF-a and IL-1b, IL-6 levels were estimated using ELISA kits in sciatic nerve according to 
the manufacturer’s instructions (R&D Systems, USA). Protein estimation was done by Bradford 
method and 100μg of proteins (lysed in lysis buffer) diluted in reagent diluents up to 100μl were 
taken for the assay as suggested by the protocol guideline.  
4.8 Histopathological measurements: 
 
The histopathological examination of the myelin sheath level in the sciatic nerve will be carried 
out to assess the extent of nerve degeneration. 
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4.9 Statistical analysis 
Data were given in the form of arithmetical mean values and standard error mean. The collected 
data were subjected to one way ANOVA (Analysis of Variance) followed by posthoc analysis 
Bonferrni multiple comparison test for MTT Assay. One way ANOVA followed by Bonferroni 
post test was used for comparing behavior models p value of less than 0.05 were considered as 
significant. The analysis was carried out by using Graph pad prism software of version 5.03. 
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5. RESULTS 
5.1 Phytochemical analysis of Desmodium gangeticum                                                            
Table:5  
 
 
 
 
 
 
 
Phytochemical screening: 
+++: Present in high concentration, ++: Present in moderate concentration and +: Present in low 
concentration   
5.2 HPTLC Finger printing  
Finger printing of Desmodium gangeticum extract,was done using HPTLC and spots were 
visualized at 254 and 366 nm. The solvent system used for development of chromatogram was 
ethyl acetate: glacial acetic acid:formic acid:water (100:1.1:1.1:26, (v/v/v/v). The brown colour 
spots obtained in chromatogram (Fig. 1) shows the presence of flavonoids in extract of 
Desmodium gangeticum. The presence of flavonoids was confirmed by derivitization with 
Dragendorff’s reagent. Quercetin was used as reference standard. A defined peak at Rf=0.34 for 
the standard flavonoid quercetin was obtained. The 3D display of the densitogram and 
chromatogram indicates the presence of quercetin like phytochemical in Desmodium gangeticum 
extract.The limit of detection was found to be 20ng/spot on siliga gel 60F254 and the linearity 
S.No Phytochemicals Presence /absence 
1. Alkaloids +++ 
2. Flavanoids 
 
+++ 
3. PHYTOSTEROL  + 
4. Tannins ++ 
5. Saponins ++ 
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range were validated in the range of 1-4 ug .  The quantity of quercetin present in the 
Desmodium gangeticum. was found to be 0.608mg/gm of extract (Fig 2) 
5.3 In vitro models 
Effect of extracts treatment on cell viability in LPS treated RAW 264.7 cells 
Treatment of RAW 264.7 cell line with aqueous extract of Desmodium gangeticum showed no 
significant decrease in cell viability in comparison to solvent treated cells. In comparison to 
solvent treated cells (100% viable cell), LPS 72 µg/ml treated cells showed significant (p<0.01) 
decrease in cell viability. Treatment of aqueous extract of Desmodium gangeticum with LPS at 
concentration 0.001 – 0.5 µg/ml   showed significant protection of RAW 264.7 cell line 
(p<0.001) in comparison to LPS treated cells. (Fig 3) 
5.4. In vivo models 
5.4.1 Hot plate method 
In comparison to sham operated group, Partial Sciatic Nerve Ligation (PSNL) operated groups 
showed significant reduction in escape latency on 7
th
 ,14
 th
   21
th
 (p<0.001)  and  28
th 
day 
(p<0.05) 
Gabapentin (30mg/kg) treated rats showed significant recovery of hyperalgesic response on 7
th
, 
14
 th
, 21
th
, 28
 th
 day as observed by increased basal latency period in comparison to PSNL group ( 
p<0.001). Desmodium gangeticum (25 & 50mg/kg) treated rats showed significant (p<0.001) 
increased in basal latency period on 7
th
, 14
 th
, 21
st
, 28
 th
  days as compared to PSNL  group.  
Desmodium gangeticum (25 mg/kg) treated rats has shown a decreased basal latency period as 
compared to Gabapentin (30mg/kg) treated rats. Desmodium gangeticum (50mg/kg) treated rats 
has shown no significant difference as compared to Gabapentin (30mg/kg) treated rats indicates 
that Desmodium gangeticum (50mg/kg) is effective as gabapentin. (Fig 4)  
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5.4.2 Randell-sellito method 
Partial Sciatic Nerve Ligation (PSNL) operated group showed significant reduction in 
mechanical hyperalgesia in comparison to sham operated group, on ,14
 th 
(p<0.001), 21
th
 
(p<0.001)  and  28
th 
day (p<0.05) Gabapentin (30mg/kg) treated rats showed significant recovery 
of hyperalgesic response on 7
th
, 14
 th
,21
th
, 28
 th
 day as observed by increased mechanical 
threshold  in comparison to PSNL group ( p<0.001). Desmodium gangeticum (25 mg/kg) treated 
rats showed significant increase in mechanical threshold   on 14
 th
(p<0.05), 21
th 
(p<0.001), 28
 th
 
(p<0.001), days as compared to PSNL operated group. Similar results were observed with 
Desmodium gangeticum (50 mg/kg). Desmodium gangeticum (50mg/kg) treated rats did not 
show significant difference with gabapentin (30mg/kg) treated rats indicates Desmodium 
gangeticum (50mg/kg) is equally efficacious as gabapentin  (Fig 5)  
5.4.3 Electronic von Frey 
In comparison to sham operated group, (PSNL) groups showed significant reduction in 
mechanical allodynia on 14
 th
 (p<0.01), 21
th
 (p<0.05)  and  28
th 
day (p<0.01) 
Gabapentin (30mg/kg) treated rats showed significant increase in mechanical allodynia on 7th, 
14
 th
, 21
th
, 28
 th
 day as observed by increase pain threshold level in comparison to PSNL rats ( 
p<0.001).  
5.4.4 ROTA ROD TEST: 
PSNL rats showed significant neurological deficits in comparison to sham-operated rats 
(p<0.001) as observed decreased time spent in rota rod test. Gabapentin (30mg/kg) treated rats 
showed a improvement (p<0.001) by increase retention time in the rotarod test on 1
st
 week. 
Desmodium gangeticum (25&50mg/kg) treated rats showed improved rotarod retention time 
(p<0.001) in the rotarod test. (Fig 7) 
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5.5 MORRIS WATER MAZE: 
Effect on time spent in the target quadrant: 
The rats significantly spent more time in the target quadrant in search of missing platform as 
compared to the time spent in other quadrants during retrieval trial conducted on day 7, 
indicating memory loss or retrieval difficulty. In PSNL group markedly reduced time spent time 
in target quadrant (Q4) in search of missing platform during retrieval trial reflects impairment of 
memory. PSNL group had a significant decrease (p<0.001) in time spent in target quadrant in 
comparison to control rats. Gabapentin (30mg/kg) and Desmodium gangeticum 
(25mg&50mg/kg) treated rats showed significant increase (p<0.001) in time spent in target 
quadrant in comparison with to PSNL rats. Treatment with Desmodium gangeticum (25 & 
50mg/kg) exhibited dose dependent increase (p<0.001) in time spent in target quadrant in 
comparison to PSNL treated rats. Desmodium gangeticum (50 mg/kg) treated rats has shown a 
significant reduction in time spent in target quadrant as compared to gabapentin (30mg/kg) 
treated rats (p<0.001) (Fig 8.1) 
Effect on time to reach the target quadrant: 
The decrease in time to reach the target quadrant indicates the memory of the animal in searching 
the missing platform. PSNL resulted in significant increase (p<0.001) in time taken to reach the 
target quadrant in comparison to control rats. Gabapentin (30mg/kg), Desmodium gangeticum 
(25&50mg/kg) treatment showed significant decrease (p<0.001) in time taken to reach the target 
quadrant in comparison to PSNL treated rats. Desmodium gangeticum (25 &50mg/kg) treatment 
exhibited dose dependent (p<0.001) effect. (Fig 8.2) 
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Effect on number of crossings: 
During retrieval trial, if the rat crosses the target quadrant many times in search of platform it 
indicates the retention of memory. PSNL surgery in rats resulted in significant decrease 
(p<0.001) in number of crossings in the target quadrant in comparison to control rats. Treatment 
with gabapentin (30mg/kg), Desmodium gangeticum (25mg/kg&50mg) showed significant 
increase (p<0.001) in number of crossings in the target quadrant in comparison to PSNL treated 
rats. gabapentin 30mg/kg, Desmodium gangeticum (25mg/kg&50mg/kg) administered rats 
exhibited dose dependent increase (p<0.05) in number of crossings of rats in the target quadrant 
in comparison to vehicle treated PSNL rats.(Fig 8.2) 
5.6 EFFECT ON NOVEL OBJECT RECOGNITION TEST: 
Time taken to initially enter and inspect objects 
The control rats significantly reach the each objects as compared to PSNL group during trial 
conducted on day 4 indicates intact cognitive functions. PSNL rats take more time to reach the 
each objects during the retrieval trial reflects impairment of memory.  
The PSNL rats spent significantly less time in exploring the novel object. This observation 
clearly indicates PSNL rats had cognitive deficits in the novel object recognition test. PSNL rats, 
resulted in significant decrease (p<0.001) in time to reach and inspect the objects compare to 
sham operated rats. Gabapentin (30mg/kg), Desmodium gangeticum (25 &50mg/kg) treatment 
showed significant increase (p<0.001) in time spent in target quadrant in comparison to PSNL 
treated rats. (Fig 9.1) 
Time taken inspecting each objects (familiar object &novel object) 
PSNL in rats resulted in increased time spent on familiar object comparison to other groups 
showing memory deficits and also in significant decrease (p<0.001) in time to reach the novel 
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object comparison to sham rats. Gabapentin (30mg/kg), Desmodium gangeticum 
(25mg&50mg/kg) treatment showed significant increase in (p<0.001) time spent in novel object 
comparison to PSNL treated rats. (Fig 9.1) 
Percentage time spending:- 
In comparison to sham operated group, PSNL operated group showed significant increase in 
percentage time spending in familiar object respectively (P<0.001). This indicates PSNL 
operated rats spent more time in familiar objects due to cognitive impairment. Treatment with 
gabapentin (30mg/kg), Desmodium gangeticum (25mg/kg&50mg) showed significant  reduction 
in percentage time spending in familiar object as compared  to PSNL operated groups  (p<0.001)  
respectively. 
5.5 Effect on pro-inflammatory mediators quantified by conventional PCR:- 
5.5.1COX measurement 
PSNL in rats resulted in significant increase (p<0.001) in pro-inflammatory mediator COX 
mRNA level when compared to control rats. Gabapentin (30 mg/kg) significantly (p<0.001) 
decreased COX mRNA level in comparison to PSNL rats. Desmodium gangeticum (25 & 
50mg/kg) treated rats showed significant (p<0.05) decrease in COX mRNA levels (Fig 10.1) 
5.5.2 e-NOS measurement 
PSNL in rats resulted in significant decrease (p<0.001) in pro-inflammatory mediator. e-NOS 
level in comparison to control rats. Gabapentin (30 mg/kg) significantly (p<0.001) increase the 
pro-inflammatory mediator level in comparison to PSNL rats. Desmodium gangeticum (25 & 
50mg/kg) showed significant (p<0.05) increase in e-NOS levels (Fig 10.2) 
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5.5.3 Effect on pro-inflammatory mediators quantified by ELISA:- 
PSNL in rats exhibited a significant increase in TNF-α, levels at (p<0.00) in comparison to sham 
operated rats. PSNL exhibited significant increase in IL-1β and IL-6 ,the  level (p<0.05) in 
comparison to sham operated rats. Gabapentin treated rats showed significant (p<0.01) reduction 
in the IL-1β and (p<0.001) IL-6 level in comparison to PSNL rats. Desmodium gangeticum 
(25mg/kg) treated rats showed significant (p<0.01) reduction in IL-1β level and (p<0.001) IL-6 
level in comparison to PSNL rats. Desmodium gangeticum (50mg/kg) treated rats significantly 
(p<0.05) reduced the TNF-α, IL-1β and IL-6 level (p<0.001) in comparsion to PSNL rats. 
Comparison to gabapentin group IL-1β and IL-6 showed significant reduction (p<0.05) at 
Desmodium gangeticum (50mg/kg) . 
5.6 Histopathalogical studies 
The axonal degeneration was evident in the negative control group (fig.11.2) as compared to the 
sham operated group (fig.11.1). The morphological picture shows normal axons on the standard 
group (fig11.3) and treatment groups (fig11.4&11.5) when compared to negative control rats 
shows decreas areas of degenerated fibers. By the end of the study period after 28 days there was 
axonal regeneration in the gabapentin treated rats and Desmodium gangeticum (25& 50mg/kg) 
treated rats. The axonal regeneration was found to be better in Desmodium gangeticum 
(25&50mg/kg) treated rats in comparison to PSNL rats and also, PSNL surgery in rats showed 
more deposition of collagen fibers which was indicative of fibrosis. The axonal regeneration in 
gabapentin (30mg/kg) treated rats was less than the sham and PSNL operated rats. 
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HPTLC analysis          
              
 
                            Figure 1: 3D value of quercetin  and desmodium gangeticum 
                          
                        Figure 2: Rf value of quercetin  and desmodium gangeticum 
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Effect of Desmodium gangeticum on LPS treated   RAW 264.7 cell lines. 
   
Figure 3. Effect of  Desmodium gangeticum on cell viability in LPS treated   RAW 264.7 
cell lines.LPS= Lipopolysaccharide All the data were expressed as mean ± SD. One way 
ANOVA followed by post-hoc tukey comparison test. 
###
, denotes the statistical significance 
in comparison to control at p<0.001 respectively.***, denotes the statistical significance in 
comparison to LPS treated cells at p<0.001, respectively. 
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Effect of Desmodium gangeticum on PSNL induced neuropathic pain in rat 
 
Figure 4. Effect of various treatments on hotplate test  
All the data were expressed as mean ± SD. Two way ANOVA followed by post hoc bonferrni 
multiple comparison test. PSNL=Partial sciatic nerve ligation GPN=Gabapentin 
DG=Desmodium gangeticum. 
#
,
##
,
###,
denotes statistical significance in comparison to sham 
treated group at p<0.05, p<0.01, p<0.001 respectively. *,**,*** denotes statistical significance in 
comparison to PSNL treated group at p<0.05, p<0.01, p<0.001 respectively. 
$
,
 $$
,
$$$
 denotes 
statistical significance in comparison to GPN treated group at p<0.05, p<0.01, p<0.001 
respectively. 
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Figure 5 Effect of various treatments on randal selito test  
All the data were expressed as mean ± SD. Two-way ANOVA followed by post hoc bonferrni 
multiple comparison test. PSNL=Partial sciatic nerve ligation. GPN=Gabapentin 
DG=Desmodium gangeticum 
#
, 
# 
,
###
,denotes statistical significance in comparison to sham 
treated group at p<0.05, p<0.01, p<0.001 respectively. *,**,***  denotes statistical significance 
in comparison to PSNL treated group at p<0.05, p<0.01, p<0.001 respectively. 
$
,
$$
,
$$$
  denotes 
statistical significance in comparison to GPN treated group at p<0.05, p<0.01, p<0.001 
respectively. 
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Figure 6 .Effect of various treatments on von frey test   
All the data were expressed as mean ± SD. Two way ANOVA followed by post hoc bonferrni 
multiple comparison test. PSNL=Partial sciatic nerve ligation .GPN=Gabapentin 
DG=Desmodium gangeticum 
#
 , denotes statistical significance in comparison to sham treated 
group at p<0.05 respectively. *,**,*** , denotes statistical significance in comparison to PSNL 
treated group at p<0.05, p<0.01, p<0.001 respectively. 
$
,
$$
,
$$$
  denotes statistical significance in 
comparison to GPN treated group at p<0.05, p<0.01, p<0.001 respectively 
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Figure 7. Effect of various treatments on rota rod test  
All the data were expressed as mean ± SD. One way ANOVA followed by post -hoc tukey 
comparison test.  PSNL=Partial sciatic nerve ligation GPN=Gabapentin DG=Desmodium 
gangeticum 
###
, denotes statistical significance in comparison to sham treated group at p<0.001 
respectively. ***, denotes statistical significance in comparison to PSNL treated group at 
p<0.001 respectively.  
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Training 
Effect on time spent in the target quadrant: 
 
Figure 8.1: Effect of various treatments on morris water maze test  
All the data were expressed as mean ± SD. One way ANOVA followed by post hoc tukey 
comparison test. PSNL=Partial sciatic nerve ligation GPN=Gabapentin DG=Desmodium 
gangeticum 
###
, denotes statistical significance in comparison to sham treated group at p<0.001 
respectively. ***, denotes statistical significance in comparison to PSNL treated group at 
p<0.001 respectively 
$$$
, denotes statistical significance in comparison to GPN treated group at 
p<0.001 respectively 
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Time to reach target quadrant:- 
 
No of crossing:- 
 
Figure 8.2: Effect of various treatments on morris water maze test  
All the data were expressed as mean ± SD. One way ANOVA followed by post hoc tukey 
comparison test. PSNL=Partial sciatic nerve ligation GPN=Gabapentin DG=Desmodium 
gangeticum 
##
, denotes statistical significance in comparison to sham treated group at p<0.01 
respectively. ***, denotes statistical significance in comparison to PSNL treated group at 
p<0.001 respectively. 
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NOVEL OBJECT RECOGNITION TEST 
Time taken into initially enter the objects  
Time spent in center zone 
 
 
RESULTS 
 
DEPARTMENT OF PHARMACOLOGY, PSG COLLEGE OF PHARMACY. Page 60   
 
 
 
Time taken to initially enter and inspect objects 
 
 
Figure 9.1: Effect of various treatments on novel object recognition test.  
All the data were expressed as mean ± SD. One way ANOVA followed by post hoc tukey 
comparison test.PSNL=Partial sciatic nerve ligation GPN=Gabapentin DG=Desmodium 
gangeticum 
#
, denotes statistical significance in comparison to sham treated group at p<0.05 
respectively. *,***, denotes statistical significance in comparison to PSNL treated group at 
p<0.01,p<0.001 respectively . 
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Time taken inspecting each objects: (familiar object &novel object) 
 
TIME SPENDING (%):- 
    
 
Figure 9.2: Effect of various treatments on novel object recognition test. All the data were 
expressed as mean ± SD. One way ANOVA followed by post hoc tukey comparison 
test.PSNL=Partial sciatic nerve ligation GPN=Gabapentin DG=Desmodium gangeticum.   
###
, 
denotes statistical significance in comparison to sham treated group at p<0.001 respectively. ***, 
denotes statistical significance in comparison to PSNL treated group at p<0.001 respectively. 
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PCR STUDIES 
 
cox 
 
e-NOS 
 
GAPDH 
COX  
 
 
Figure 10.1: Quantification of cox mRNA level expression by conventional PCR .all the data 
were expressed as  mean ± SD. One way ANOVA followed by post hoc tukey comparison test . 
PSNL=Partial sciatic nerve ligation GPN=Gabapentin DG=Desmodium gangeticum 
###
, denotes statistical significance in comparison to sham treated group at p<0.001 
respectively.***, denotes statistical significance in comparison to PSNL treated group at p<0.001 
respectively.
$$$
, denotes statistical significance in comparison to GPN treated group at p<0.001 
respectively. 
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e-NOS   
 
Figure 10.2: Quantification of e-NOS mRNA level expression by conventional PCR .All the 
data were expressed as  mean ± SD. One way ANOVA followed by post hoc tukey comparison 
test . PSNL=Partial sciatic nerve ligation GPN=Gabapentin  DG=Desmodium gangeticum. 
###
, 
denotes statistical significance in comparison to sham treated group at p<0.001 respectively.***, 
denotes statistical significance in comparison to PSNL treated group at p<0.001 respectively. 
$$$
, 
denotes statistical significance in comparison to GPN treated group at p<0.001 respectively. 
ELISA TEST:- 
 
TNF-α 
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IL-1β 
 
                
 
 
 
IL-6 
 
 
 
 
Figure 11:  Quantification Of Tnf-α, Il-1β AND IL-6 Level By Elisa. All the data were 
expressed as mean ± SD. One way ANOVA followed by post hoc tukey comparison test. 
PSNL=Partial sciatic nerve ligation GPN=Gabapentin DG=Desmodium gangeticum 
#
, denotes 
statistical significance in comparison to sham treated group at p<0.05 respectively.*, **,***  
denotes statistical significance in comparison to PSNL treated group at p<0.05, p<0.01, p<0.001 
respectively. 
$
, 
$$
, denotes statistical significance in comparison to GPN treated group at p<0.05, 
P<0.01 respectively. 
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HISTOPATHOLOGY STUDIES 
Sham Operated 
Section studied from sciatic nerve shows normal axons, fibrocytes and  
schwann cells with focal degenerations noted. No evidence of inflammation/granuloma seen 
  
                          
                               10x 
  
                             
                              40x 
 
Figure 12.1: Microscopic observation  
 
PSNL 
 
Section studied from sciatic nerve shows normal axons, fibrocytes and schwann cells and  
nodes of  ranvier with focal mild swelling of endoneurium. 
   
                        
                         10X                                                                                     40X 
Figure 12.2: MICROSCOPIC APPEARANCE 
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GABAPENTIN (30mg/kg) 
Section studied from sciatic nerve .shows normal axons, fibrocytes and schwann cells, nodes of  
Ranvies, myelin sheeth and endoneurium. No inflammation/granuloma seen 
 
                                    10x 
 
                              40x 
Figure 12.3: MICROSCOPIC APPEARANCE 
 
Desmodium gangeticum (25mg/kg) 
Section studied from sciatic nerve shows normal axons, fibrocytes and schwann cells with focal  
degenerations noted. 
 
                               
                              10x                                                                                       40X                                        
                                   Figure 12.4: MICROSCOPIC APPEARANCE 
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Desmodium gangeticum (50mg/kg) 
Section studied from sciatic nerve shows normal morphology. No evidence of 
degeneration/inflammation/granuloma. 
          
                                      10x                                                                        
  
40x 
  
                                    Figure 12.5: MICROSCOPIC APPEARANCE  
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 6. DISCUSSION 
Neuropathic pain is caused by a lesion or dysfunction affecting the nervous systems. It is often 
manifested as spontaneous pain, hyperalgesia, and allodynia. The neuropathic pain is usually 
difficult to treat because the basic etiology is heterogeneous and the underlying pathophysiology 
is complex (Bhat et al., 2016). Growing evidence indicates that inflammatory and immune 
responses contribute to neuropathic pain. In addition, neuroinflammation induced by nervous 
system injury accompanies a neuroimmune interaction that activates immune cells and leads to 
development of neuropathic pain. Desmodium gangeticum (DG) has been reported to possess 
anti-inflammatory, hepatoprotective, antiamnesic, antinociceptive and wound healing activities 
(Ghosh & Anandkumar 1983; Prasad et al. 2005; Jain et al. 2006). The preliminary study on LPS 
stimulated RAW 264.7 cell lines revealed that Desmodium gangeticum (DG) posses anti-
inflammatory activity in vitro. 
Kim et al. reported that the partial sciatic nerve ligation(PSNL) neuropathic pain model produces 
significant responses to the hot-plate test, von Frey test and, supporting its usefulness and 
appropriateness in pain investigations for thermal hyperalgesia and mechanical allodynia. In our 
study, the results of the behavioral tests in PSNL operated rats have shown similar pain 
responses. The aqueous extract of Desmodium gangeticum attenuated the thermal hyperalgesia 
suggesting it may act via central through inhibitory nerve sensitivity. It has been reported that 
small unmyelinated and large myelinated primary nerves (Aβ and small-diameter nociceptive 
fibres) are implicated in mechanical allodynia (Field et al., 1999). In our study, the aqueous 
extract of Desmodium gangeticum reversed the thermal allodynia induced by PSNL model. 
Mechanical hyperalgesia resulting from tissue injury or inflammation is often associated with 
sensitization of TRPV1 channel activity which can occur through several mechanisms such as 
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phosphorylation, interaction with phospholipid PIP2, trafficking, and association with accessory 
proteins. Many studies have implicated TRPV1 in the modulation of sensory transmission from 
the central terminals of primary afferents to spinal dorsal horn neurons (Kim et al., 2014; Choi et 
al., 2016). The aqueous extract of Desmodium gangeticum attenuated the hyperalgesia which 
suggest it may act through by inhibiting TRPV1 receptors.  
Partial peripheral nerve injury leads to chronic pain states such as causalgia. The symptoms 
include spontaneous burning pain, thermal hyperalgesia and mechanical allodynia in the affected 
area which was also observed in our study.  It is known that the axotomized sensory afferents 
produce abnormal spontaneous discharges (Han et al., 2000) leading  to central sensitization, a 
state of increased excitability of spinal dorsal horn nociceptive cells following prolonged 
nociceptive input (Woolf, 1983; Woolf and Doubell, 1994). The aqueous extract of Desmodium 
gangeticum attenuated the allodynia and hyperalgesia induced by PSNL which suggest it may be 
useful in causalgia form  pain disorders. 
In our study, PSNL operated rats displayed significant mechanical allodynia, thermal and 
mechanical hyperalgesia, Neuropathic pain not only impacts negatively on physical and but 
psycho-logical functioning also. Impairments in cognitive domains including attention and 
working memory have been demonstrated in chronic pain patients using both subjective reports 
and objective neuropsychological testing (orla moriarty et al., 2016).In our study PSNL surgery 
affected spatial learning or memory in the traditional water-maze task. Hu et al., found 
impairments in a similar task in an L5-transection model of neuropathic pain. Further, treatment 
of aqueous extract of Desmodium gangeticum to PSNL rats reversed the cognitive impairment 
evaluated by morris water maze test. 
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In the novel-object recognition task, PSNL rats showed no preference for the novel object 
compared with the familiar object, and their exploration of the novel object was reduced 
compared with that of the sham operated group. This indicates a specific deficit in recognition 
memory and concordance with previous studies (orla moriarty et al., 2016). Previous studies 
have shown deficits in novel-object recognition associated with pain in sprague dawley rats in an 
inflammatory pain model (wen-jie-ren et al., 2011) and in mouse neuropathic pain model. The 
treatment of aqueous extract of Desmodium gangeticum to PSNL rats improved the recognition 
memory suggesting it may alleviate pain associated memory impairment. In spared nerve injury 
(SNI) model of neuropathic pain, over-production of TNF-α following peripheral nerve injury 
has lead to neuropathic pain associated memory deficits and their inhibition of TNF-α or genetic 
deletion of TNF receptor 1 prevented both memory deficits and synaptic dysfunction induced by 
SNI (wen-jie-ren et al., 2011). 
Several studies have reported that pro-inflammatory cytokines such as tumor necrosis factor 
(TNF-α), interleukin-1 (IL-1β & IL-6) and nuclear factor-kappa B (NF-κB) may contribute to 
pathogenesis of neuropathic pain, with peripheral and or central nervous system mechanisms. 
Pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor TNF-α 
are produced after nerve injury and play an essential role in neuropathic pain sensitization 
(Strichartz et al., 2004, Cheng et al., 2008a). IL- 1β and TNF- α play an important role in the 
amplification loop of the nociceptive response as they can stimulate their own and each other’s 
production (Dinarello et al., 1997). The activated microglia mainly produces these toxic 
cytokines IL-1, IL-6, & TNF- α as well as nitric oxide, excitatory amino acids, ATP, and 
prostaglandins in neuropathic pain (Inoue, 2006). Our study has shown that aqueous extract of 
Desmodium gangeticum down regulated TNFα and IL1β at nerve levels in PSNL pain model. 
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The aqueous extract of Desmodium gangeticum also down regulated the level of IL-6 in PSNL 
pain model.  
Inflammatory cytokines induce COX-2 in which manifests inflammatory pain via PG in various 
cells and selective inhibitors of COX-2 block pain in inflammatory models and are studied in 
clinical trials (Shigeru Kobayash et al., 2015). The COX-2 expressing cell profiles were present 
in 2
nd
 and 4
th
 week injured sciatic nerve following partial sciatic nerve ligation.  Ma et al. 
demonstrated that partial nerve injury induces more abundant COX-2 expression than complete 
nerve injury (Talmar et al., 2003). In the study, PSNL operated rats had elevated cox-2 levels 
and their expression was down regulated by treatment of aqueous extract of Desmodium 
gangeticum. 
eNOS is mainly produced by endothelial cells and may be produced by Schwann cells 
(Kobayashi et al., 2009). WEN-NING QI, et al., 2001 studied the expression of different nitric 
oxide synthases in ischemia-reperfused peripheral nerve of the rat. In his study, after 3 h of 
reperfusion, expression of eNOS mRNA and protein was down regulated, that lead to neuronal 
cell damage. In our study, PSNL operated rats had reduced eNOS mRNA levels and treatment of 
aqueous extract of Desmodium gangeticum. pwere unregulated  their  mRNA  levels  in PSNL 
injured  rats. 
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7. SUMMARY & CONCLUSION 
 The present study aimed to evaluate the aqueous extract of Desmodium gangeticum 
for its protective effect in neuropathic pain activity by using in vitro and in vivo 
models like LPS induced inflammation in murine macrophages and PSNL model to 
induce neuropathic pain in rats. 
 We observed the pain and memory functions condition of animals by inducing 
neuropathic pain using PSNL model in rats. To elucidate the mechanism of action 
protective effect in neuropathic pain, pro-inflammatory mediators were measured. To 
support these studies histopathological studies is carried out.  
 PSNL rats showed that significant decrease in pain threshold in pain behaviour studies 
such as thermal, mechanical allodynia and hyperalgesia and reduced motor 
coordination and cognitive impairment functions.  
 Aqueous extract of Desmodium gangeticum was prepared by water decoction process. 
Quantification through HPTLC studies revealed that Desmodium gangeticum 
contained 0.608mg/g amounts of Quercetin.  
 Desmodium gangeticum exhibited dose dependent protection in cell viability in LPS 
induced inflammation in murine macrophages.   
 The aqueous extract of Desmodium gangeticum show significant increase in pain 
threshold in pain behaviour studies such as thermal, mechanical allodynia and 
hyperalgesia. 
 The aqueous extract of Desmodium gangeticum improved motor coordination and 
cognitive impairment.  
 The aqueous extract of DG showed significant decrease in pro-inflammatory 
mediators like TNF-α, IL- 1β, IL-6, COX-2 which shows that anti-inflammatory 
mechanism of  Desmodium gangeticum.  
The study can be concluded that treatment of Desmodium gangeticum in PSNL induced rat 
reduced mechanical and thermal hyperalgesia and allodynia. It also improved the long term 
spatial memory and recognition memory. They exert their activity by inhibiting pro 
inflammatory mediator such as TNF-α, IL- 1β, IL-6, and COX-2 in PSNL affected nerves. 
The outcome of the study is that the aqueous extract of Desmodium gangeticum may be a 
potential therapeutic usage as novel anti nociceptive and cognitive impairment therapy in 
chronic neuropathic condition. 
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